Research outputs

Publications

All peer-reviewed publications till date

Filter by fieldAll Precision medicine Rare diseases Psychoactive drugs Other

2026Genetic Susceptibility to Anthracycline-Induced Cardiotoxicity in Australian Pediatric Cancer PatientsHalman, A, Netylko, J, Stolper, J, Rossello, F, Ludlow, L, Mateos, M, Celermajer, D, Kumar, S, Elliott, D, Conyers, RJACC: Advances, doi: 10.1016/j.jacadv.2026.103105Precision Medicine 2026Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5-HT3 Receptor Antagonists: 2026 UpdateMoore, C, Bourque, M, Halman, A, Agúndez, J, Prows, C, Hikino, K, Schwab, M, Oxencis, C, Chauhan, D, Diekstra, M, Long, S, Bell, G, Gaedigk, A, Whirl‐Carrillo, M, Klein, T, Caudle, K, Conyers, RClinical Pharmacology & Therapeutics, doi: 10.1002/cpt.70291Precision Medicine 2026Tacrolimus in Pediatric Solid Organ Transplant Recipients: A Retrospective Cohort StudyKhatri, D, Netylko, J, Metz, D, Sun, Y, Kausman, J, Mathew, J, Bannister, E, Gwee, A, Christodoulou, J, Stenta, T, Moore, C, Williams, E, Dyas, R, Stolper, J, Halman, A, Conyers, RPediatric Transplantation, doi: 10.1111/petr.70370Precision Medicine 2025Phenoconversion of CYP3A4, CYP2C19 and CYP2D6 in Pediatrics, Adolescents and Young Adults With Lymphoma: Rationale and Design of the PEGASUS StudyConyers, R, Stenta, T, Somogyi, A, Kirkpatrick, C, Halman, A, Wang, S, Moore, C, Khatri, D, Williams, E, Dyas, R, Spelman, T, Elliott, D, Gwee, A, Alexander, MClinical and Translational Science, doi: 10.1111/cts.70209Precision Medicine 2025Frequency and Implications of High-Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology CohortMoore, C, Halman, A, Stenta, T, Khatri, D, Williams, E, Dyas, R, Stolper, J, Elliott, D, Conyers, RClinical and Translational Science, doi: 10.1111/cts.70246Precision Medicine 2025BCyrius: An Upgraded Version of Cyrius for Accurate CYP2D6 Genotyping From Short-Read Sequencing DataHalman, A, Conyers, RPharmacology Research & Perspectives, doi: 10.1002/prp2.70065Precision Medicine 2025CYP2D6 genotype and associated 5-HT3 receptor antagonist outcomes: A systematic review and meta-analysisMoore, C, Williams, E, Dyas, R, Halman, A, Stenta, T, Khatri, D, Elliott, D, Lange, P, Caudle, K, Conyers, RClinical and Translational Science, doi: 10.1111/cts.70108Precision Medicine 2024Pharmacogenomic studies of fertility outcomes in pediatric cancer survivors: A systematic reviewStenta, T, Assis, M, Ayers, K, Tucker, E, Halman, A, Gook, D, Sinclair, A, Elliott, D, Jayasinghe, Y, Conyers, RClinical and Translational Science, doi: 10.1111/cts.13827Precision Medicine 2024Minimising Adverse Drug Reactions and Verifying Economic Legitimacy-Pharmacogenomics Implementation in Children (MARVEL-PIC): protocol for a national randomised controlled trial of pharmacogenomics implementationConyers, R, Halman, A, Moore, C, Stenta, T, Felmingham, B, Collier, L, Khatri, D, Spelman, T, Williams, E, Dyas, R, Kotecha, R, Jessop, S, Mateos, M, Swen, J, Elliott, DBMJ Open, doi: 10.1136/bmjopen-2024-085115Precision Medicine 2024Benchmarking pharmacogenomics genotyping tools: Performance analysis on short-read sequencing samples and depth-dependent evaluationHalman, A, Lunke, S, Sadedin, S, Moore, C, Conyers, RClinical and Translational Science, doi: 10.1111/cts.13911Precision Medicine